Bionovo
Bionovo is a privately held, late-stage clinical drug discovery and development company founded in 2002 and based in Emeryville, California, focused on women's health and oncology therapeutics, with no publicly disclosed pipeline, commercial activity, or recent funding.
- Company typePrivate
- Founded2002
- HeadquartersEmeryville, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
Bionovo firmographics
Firmographics- Name
- Bionovo
- Website
- https://bionovo.com
- Company type
- Private
- Founded year
- 2002
- Headcount range
- 51–100 employees
- Short description
- Bionovo is a privately held, late-stage clinical drug discovery and development company founded in 2002 and based in Emeryville, California, focused on women's health and oncology therapeutics, with no publicly disclosed pipeline, commercial activity, or recent funding.
- Ownership category
- akta.pro rank
Bionovo industry classification
Industry- Product category
- Clinical-stage Drug Development
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
Keywords
Where Bionovo is headquartered
LocationHeadquarters
- HQ city
- Emeryville
- HQ country
- United States
- HQ region
- North America
Markets served
Bionovo business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations
Bionovo product offering
Product offeringCore offering
Bionovo is a late-stage clinical drug discovery and development company that focuses on women's health and oncology therapeutics. The company develops pharmaceutical candidates and advances them through clinical trials, targeting indications in women's health and cancer.
Differentiator
Problem solved
Functional benefit
Companies that use Bionovo
Customer profileIdeal customer profiles1 record
Bionovo technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bionovo competitors and assessment
Company assessmentDirect peers
- Veru Inc. Clinical-stage biopharmaceutical company developing therapeutics in both women's health (especially breast cancer and menopause) and oncology. Closely comparable to Bionovo because of the shared dual focus on women's health and oncology clinical assets.
- Radius Health: Clinical-stage biopharmaceutical company historically focused on women's health and osteoporosis therapeutics. Comparable therapeutic focus area and clinical-stage operating profile.
- TherapeuticsMD: Clinical-stage biopharmaceutical company focused on women's health, particularly menopausal and reproductive health therapeutics. Directly comparable as a women's-health-focused biotech advancing clinical assets.
- Daré Bioscience: Clinical-stage biopharmaceutical company with a women's health pipeline spanning contraception, sexually transmitted infections, and menopause. Comparable as a women's-health-focused clinical biotech.
- Sermonix Pharmaceuticals: Clinical-stage pharmaceutical company focused on women's health, particularly breast cancer treatments and menopausal symptoms. Directly comparable therapeutic focus on women's health and oncology.
- ObsEva: Clinical-stage biopharmaceutical company developing therapeutics for women's reproductive health. Comparable as a women's-health-focused biotech advancing clinical assets in adjacent indications.
Broad incumbents
- Pfizer: Major pharmaceutical company with significant women's health and oncology franchises across multiple modalities. Comparable as a broad incumbent operating in both therapeutic areas Bionovo targets.
- Hologic: Large medical technology company focused on women's health through diagnostics, devices, and surgical products. Comparable as a women's-health-focused player, though operating in adjacent rather than overlapping therapeutic segments.
- Organon: Large established women's health company spun off from Merck with a broad portfolio of women's health products. Comparable as a major women's health player, though at much larger scale and broader scope than Bionovo.
Emerging players
- Celcuity: Clinical-stage biotechnology company developing targeted therapies for oncology, particularly breast cancer. Comparable as a clinical-stage oncology-focused biotech with partial overlap to Bionovo's cancer focus.
Market position
Customer concentration
Bionovo social profiles
Digital presenceBionovo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bionovo leadership team
Management profileNumber of profiles
Bionovo funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bionovo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bionovo
What does Bionovo do?
Bionovo is a late-stage clinical drug discovery and development company that focuses on women's health and oncology therapeutics. The company develops pharmaceutical candidates and advances them through clinical trials, targeting indications in women's health and cancer.
Is Bionovo a public or private company?
Bionovo is a private company. It is classified as unknown.
When was Bionovo founded?
Bionovo was founded in 2002. It employs 51 to 100 people.
Where is Bionovo based?
Bionovo is headquartered in Emeryville, United States, in the North America region.
Who are Bionovo's main competitors?
Direct peers on record are Veru Inc., Radius Health, TherapeuticsMD, Daré Bioscience, Sermonix Pharmaceuticals and ObsEva. Broad incumbents are Pfizer, Hologic and Organon. Celcuity is listed as an emerging player.
Does Bionovo have an API?
No public API is recorded for Bionovo.
What industry is Bionovo in?
Bionovo's product category is Clinical-stage Drug Development. Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays). Its NAICS code is 541714 and its SIC code is 2834.